BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rapado-González Ó, Majem B, Muinelo-Romay L, Álvarez-Castro A, Santamaría A, Gil-Moreno A, López-López R, Suárez-Cunqueiro MM. Human salivary microRNAs in Cancer. J Cancer 2018;9:638-49. [PMID: 29556321 DOI: 10.7150/jca.21180] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Dar GM, Agarwal S, Kumar A, Nimisha, Apurva, Sharma AK, Verma R, Sattar RSA, Ahmad E, Ali A, Mahajan B, Saluja SS, Meher R. A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer. Critical Reviews in Oncology/Hematology 2022;180:103850. [DOI: 10.1016/j.critrevonc.2022.103850] [Reference Citation Analysis]
2 Davies M, Davey MG, Miller N. The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment. Genes 2022;13:2054. [DOI: 10.3390/genes13112054] [Reference Citation Analysis]
3 Bocchetti M, Grisolia P, Melisi F, Ferraro MG, De Luca P, Camaioni A, Falco M, Abate M, Misso G, Alfano R, Accardo N, Oliva F, Cossu AM, Caraglia M, Scrima M, Ricciardiello F. MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis. Cancers 2022;14:5304. [DOI: 10.3390/cancers14215304] [Reference Citation Analysis]
4 Zamarian V, Stefanello D, Ferrari R, Chiti LE, Grieco V, Dallacosta E, Ceciliani F, Lecchi C. Salivary miR-21 is a potential biomarker for canine mast cell tumors. Vet Pathol 2022. [DOI: 10.1177/03009858221128922] [Reference Citation Analysis]
5 Faur CI, Roman RC, Jurj A, Raduly L, Almășan O, Rotaru H, Chirilă M, Moldovan MA, Hedeșiu M, Dinu C. Salivary Exosomal MicroRNA-486-5p and MicroRNA-10b-5p in Oral and Oropharyngeal Squamous Cell Carcinoma. Medicina (Kaunas) 2022;58. [PMID: 36295638 DOI: 10.3390/medicina58101478] [Reference Citation Analysis]
6 Sullivan R, Montgomery A, Scipioni A, Jhaveri P, Schmidt AT, Hicks SD. Confounding Factors Impacting microRNA Expression in Human Saliva: Methodological and Biological Considerations. Genes (Basel) 2022;13:1874. [PMID: 36292760 DOI: 10.3390/genes13101874] [Reference Citation Analysis]
7 Liu X, Papukashvili D, Wang Z, Liu Y, Chen X, Li J, Li Z, Hu L, Li Z, Rcheulishvili N, Lu X, Ma J. Potential utility of miRNAs for liquid biopsy in breast cancer. Front Oncol 2022;12:940314. [DOI: 10.3389/fonc.2022.940314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Koopaie M, Kolahdooz S, Fatahzadeh M, Manifar S. Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta-analysis. Cancer Med 2022. [PMID: 35315584 DOI: 10.1002/cam4.4640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Ratnasari N, Lestari P, Renovaldi D, Raditya Ningsih J, Qoriansas N, Wardana T, Hakim S, Signa Aini Gumilas N, Indrarti F, Triwikatmani C, Bayupurnama P, Setyo Heriyanto D, Astuti I, Mubarika Harjana S. Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients. PLoS One 2022;17:e0263298. [PMID: 35157721 DOI: 10.1371/journal.pone.0263298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mariam A, Miller-Atkins G, Moro A, Rodarte AI, Siddiqi S, Acevedo-Moreno LA, Brown JM, Allende DS, Aucejo F, Rotroff DM. Salivary miRNAs as non-invasive biomarkers of hepatocellular carcinoma: a pilot study. PeerJ 2022;10:e12715. [PMID: 35036096 DOI: 10.7717/peerj.12715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Eftekhari A, Maleki Dizaj S, Sharifi S, Salatin S, Khalilov R, Samiei M, Zununi Vahed S, Ahmadian E. Salivary biomarkers in cancer. Advances in Clinical Chemistry 2022. [DOI: 10.1016/bs.acc.2022.06.005] [Reference Citation Analysis]
12 Koopaie M, Abedinejad F, Manifar S, Mousavi R, Kolahdooz S, Shamshiri A. Salivary miRNA-21 expression as a potential non-invasive diagnostic biomarker in breast cancer. Gene Reports 2021;25:101317. [DOI: 10.1016/j.genrep.2021.101317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Prasad SR, Pai A, Shyamala K, Yaji A. Expression of Salivary miRNA 21 in Oral Submucous Fibrosis (OSMF): An Observational Study. Microrna 2020;9:295-302. [PMID: 31985389 DOI: 10.2174/2211536609666200127143749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Faur CI, Rotaru H, Osan C, Jurj A, Roman RC, Moldovan M, Chirila M, Hedesiu M. Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review. Maxillofac Plast Reconstr Surg 2021;43:19. [PMID: 34191144 DOI: 10.1186/s40902-021-00303-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
15 Ying L, Jian C, Ma X, Ge K, Zhu W, Wang Y, Zhao A, Zhou J, Jia W, Bao Y. Saliva 1,5-anhydroglucitol is associated with early-phase insulin secretion in Chinese patients with type 2 diabetes. BMJ Open Diabetes Res Care 2021;9:e002199. [PMID: 34167955 DOI: 10.1136/bmjdrc-2021-002199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Nguyen HT, Kacimi SEO, Nguyen TL, Suman KH, Lemus-Martin R, Saleem H, Do DN. MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology (Basel) 2021;10:417. [PMID: 34066762 DOI: 10.3390/biology10050417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
17 Leung WH, Pang CC, Pang SN, Weng SX, Lin YL, Chiou YE, Pang ST, Weng WH. High-Sensitivity Dual-Probe Detection of Urinary miR-141 in Cancer Patients via a Modified Screen-Printed Carbon Electrode-Based Electrochemical Biosensor. Sensors (Basel) 2021;21:3183. [PMID: 34063705 DOI: 10.3390/s21093183] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
18 Rovas A, Puriene A, Snipaitiene K, Punceviciene E, Buragaite-Staponkiene B, Matuleviciute R, Butrimiene I, Jarmalaite S. Analysis of periodontitis-associated miRNAs in gingival tissue, gingival crevicular fluid, saliva and blood plasma. Arch Oral Biol 2021;126:105125. [PMID: 33862403 DOI: 10.1016/j.archoralbio.2021.105125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Dong X, Li Y, Cao R, Xu H. MicroRNA-363-3p Inhibits the Expression of Renal Fibrosis Markers in TGF-β1-Treated HK-2 Cells by Targeting TGF-β2. Biochem Genet 2021;59:1033-48. [PMID: 33630202 DOI: 10.1007/s10528-021-10044-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Menini M, De Giovanni E, Bagnasco F, Delucchi F, Pera F, Baldi D, Pesce P. Salivary Micro-RNA and Oral Squamous Cell Carcinoma: A Systematic Review. J Pers Med 2021;11:101. [PMID: 33557138 DOI: 10.3390/jpm11020101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
21 Kusampudi S, Konduru N. Salivary Biomarkers for Non-invasive Early Detection of Head and Neck Cancer. Early Detection and Treatment of Head & Neck Cancers 2021. [DOI: 10.1007/978-3-030-69859-1_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Farshbaf A, Mohtasham N, Zare R, Mohajertehran F, Rezaee SA. Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities. J Oral Biol Craniofac Res 2021;11:132-7. [PMID: 33398242 DOI: 10.1016/j.jobcr.2020.12.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
23 Konečná B, Gaál Kovalčíková A, Pančíková A, Novák B, Kovaľová E, Celec P, Tóthová Ľ. Salivary Extracellular DNA and DNase Activity in Periodontitis. Applied Sciences 2020;10:7490. [DOI: 10.3390/app10217490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Vacante M, Ciuni R, Basile F, Biondi A. The Liquid Biopsy in the Management of Colorectal Cancer: An Overview. Biomedicines. 2020;8. [PMID: 32858879 DOI: 10.3390/biomedicines8090308] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
25 Shin PK, Kim MS, Park SJ, Kwon DY, Kim MJ, Yang HJ, Kim SH, Kim K, Chun S, Lee HJ, Choi SW. A Traditional Korean Diet Alters the Expression of Circulating MicroRNAs Linked to Diabetes Mellitus in a Pilot Trial. Nutrients 2020;12:E2558. [PMID: 32846929 DOI: 10.3390/nu12092558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Deutsch FT, Khoury SJ, Sunwoo JB, Elliott MS, Tran NT. Application of salivary noncoding microRNAs for the diagnosis of oral cancers. Head Neck 2020;42:3072-83. [PMID: 32686879 DOI: 10.1002/hed.26348] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
27 Han P, Bartold PM, Salomon C, Ivanovski S. Salivary Small Extracellular Vesicles Associated miRNAs in Periodontal Status-A Pilot Study. Int J Mol Sci 2020;21:E2809. [PMID: 32316600 DOI: 10.3390/ijms21082809] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
28 Zhang L, Wu H, Zhao M, Chang C, Lu Q. Clinical significance of miRNAs in autoimmunity. J Autoimmun 2020;109:102438. [PMID: 32184036 DOI: 10.1016/j.jaut.2020.102438] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
29 Kashyap D, Kaur H. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction. Life Sci 2020;246:117417. [PMID: 32044304 DOI: 10.1016/j.lfs.2020.117417] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
30 Setti G, Pezzi ME, Viani MV, Pertinhez TA, Cassi D, Magnoni C, Bellini P, Musolino A, Vescovi P, Meleti M. Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review. Int J Mol Sci. 2020;21. [PMID: 32019170 DOI: 10.3390/ijms21030907] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
31 Ciro Comparetto, Franco Borruto. Liquid Biopsy: A New, Non-Invasive Early Diagnostic and Prognostic Tool in Oncology. J Can Res Updates 2020;9:37-68. [DOI: 10.30683/1929-2279.2020.09.06] [Reference Citation Analysis]
32 Kuhlman KR, Mousavi Z. Applications of Salivary Bioscience to Precision Medicine. Salivary Bioscience 2020. [DOI: 10.1007/978-3-030-35784-9_29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Rapado-González Ó, López-López R, López-Cedrún JL, Triana-Martínez G, Muinelo-Romay L, Suárez-Cunqueiro MM. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy. Cells 2019;8:E1653. [PMID: 31861130 DOI: 10.3390/cells8121653] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
34 Powrózek T, Porgador A, Małecka-massalska T. Detection, prediction, and prognosis: blood circulating microRNA as novel molecular markers of head and neck cancer patients. Expert Review of Molecular Diagnostics 2020;20:31-9. [DOI: 10.1080/14737159.2020.1699062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Rapado-González O, Martínez-Reglero C, Salgado-Barreira A, López-López R, Suárez-Cunqueiro MM, Muinelo-Romay L. miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis: Systematic review and meta-analysis. Oral Oncol 2019;99:104465. [PMID: 31756680 DOI: 10.1016/j.oraloncology.2019.104465] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
36 Rapado-González Ó, Majem B, Álvarez-Castro A, Díaz-Peña R, Abalo A, Suárez-Cabrera L, Gil-Moreno A, Santamaría A, López-López R, Muinelo-Romay L, Suarez-Cunqueiro MM. A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis. J Clin Med 2019;8:E2029. [PMID: 31757017 DOI: 10.3390/jcm8122029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
37 Nowicka Z, Stawiski K, Tomasik B, Fendler W. Extracellular miRNAs as Biomarkers of Head and Neck Cancer Progression and Metastasis. Int J Mol Sci 2019;20:E4799. [PMID: 31569614 DOI: 10.3390/ijms20194799] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
38 Ding S, Song X, Geng X, Liu L, Ma H, Wang X, Wei L, Xie L, Song X. Saliva-derived cfDNA is applicable for EGFR mutation detection but not for quantitation analysis in non-small cell lung cancer. Thorac Cancer 2019;10:1973-83. [PMID: 31441578 DOI: 10.1111/1759-7714.13178] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
39 Hsieh YT, Chen YF, Lin SC, Chang KW, Li WC. Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis. Int J Mol Sci 2019;20:E3960. [PMID: 31416244 DOI: 10.3390/ijms20163960] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
40 Jin Y, Wong YS, Goh BKP, Chan CY, Cheow PC, Chow PKH, Lim TKH, Goh GBB, Krishnamoorthy TL, Kumar R, Ng TP, Chong SS, Tan HH, Chung AYF, Ooi LLPJ, Chang JPE, Tan CK, Lee CGL. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Sci Rep. 2019;9:10464. [PMID: 31320713 DOI: 10.1038/s41598-019-46872-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 19.7] [Reference Citation Analysis]
41 Zhang Y, Yan J, Pan X. miR-141-3p affects apoptosis and migration of endometrial stromal cells by targeting KLF-12. Pflugers Arch - Eur J Physiol 2019;471:1055-63. [DOI: 10.1007/s00424-019-02283-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
42 Zygula A, Kosinski P, Zwierzchowska A, Sochacka M, Wroczynski P, Makarewicz-Wujec M, Pietrzak B, Wielgos M, Rzentala M, Giebultowicz J. Oxidative stress markers in saliva and plasma differ between diet-controlled and insulin-controlled gestational diabetes mellitus. Diabetes Res Clin Pract 2019;148:72-80. [PMID: 30529575 DOI: 10.1016/j.diabres.2018.11.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
43 Wang J, Liang H, Ge H, Guo X, Gu D, Yuan Y. MicroRNA‑363‑3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage. Mol Med Rep 2019;19:935-42. [PMID: 30535489 DOI: 10.3892/mmr.2018.9711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
44 Mafi A, Aghadavod E, Mirhosseini N, Mobini M, Asemi Z. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression. J Cell Physiol 2019;234:42-50. [DOI: 10.1002/jcp.26895] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
45 Bookland M, Tang-Schomer M, Gillan E, Kolmakova A. Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma patients predicts mural nodule volume. Acta Neurochir (Wien) 2018;160:1571-81. [PMID: 29911246 DOI: 10.1007/s00701-018-3589-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
46 Gao W, Hua J, Jia Z, Ding J, Han Z, Dong Y, Lin Q, Yao Y. Expression of miR-146a-5p in breast cancer and its role in proliferation of breast cancer cells. Oncol Lett 2018;15:9884-8. [PMID: 29928360 DOI: 10.3892/ol.2018.8589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]